TuHURA Biosciences adopted a 2026 inducement Equity plan reserving 5,000,000 common shares for awards to eligible new employees. The plan matters to investors because it is intended to attract individuals to employment through equity-based and cash incentive awards, while allowing qualifying grants without stockholder approval under Nasdaq Listing Rule 5635.

Key Highlights

  • The plan is intended for equity awards that induce eligible individuals to join TuHURA Biosciences or its subsidiaries.
  • TuHURA adopted the plan without stockholder approval under Nasdaq Listing Rule 5635.
  • TuHURA Biosciences reserved 5,000,000 common shares under the 2026 inducement equity incentive plan.

TuHURA Biosciences, Inc. (NASDAQ: HURA) adopted a 2026 inducement equity incentive plan that reserves 5,000,000 shares of common stock for potential awards. The plan is intended to help attract new employees to TuHURA Biosciences or its subsidiaries through equity-based and cash incentives. Qualifying grants can be made without stockholder approval under Nasdaq Listing Rule 5635. The Board adopted the plan on sep 10, 2026.

5M Shares Reserved for Employee Awards

Its reserved securities are common stock with a Par Value of $0.001 per share. Incentive stock Options are excluded. The Compensation Committee administers the plan. Awards may be approved by that committee when it consists only of independent directors, or by a majority of TuHURA Biosciences’ independent directors. Awards issued under other equity compensation plans remain subject to those plans and their existing award agreements.